CYTOKINETICS INC·4

Nov 9, 5:35 PM ET

Cragg David 4

4 · CYTOKINETICS INC · Filed Nov 9, 2021

Insider Transaction Report

Form 4
Period: 2021-11-09
Cragg David
V.P., Human Resources
Transactions
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2021-11-0920,4810 total
    Exercise: $9.65From: 2014-03-24Exp: 2024-02-24Common Stock (20,481 underlying)
  • Exercise/Conversion

    Common Stock

    2021-11-09$9.65/sh+24,519$236,608163,223 total
  • Sale

    Common Stock

    2021-11-09$41.76/sh24,519$1,023,918138,704 total
  • Exercise/Conversion

    Common Stock

    2021-11-09$9.65/sh+20,481$197,642159,185 total
  • Sale

    Common Stock

    2021-11-09$41.76/sh20,481$855,291138,704 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2021-11-0924,5190 total
    Exercise: $9.65From: 2014-03-24Exp: 2024-02-24Common Stock (24,519 underlying)
Footnotes (1)
  • [F1]Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT